Related Experiment Video
Updated: Sep 15, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Genetic Variants in Pediatric Myeloproliferative Neoplasms Revealed by Next Generation Sequencing
Background:
Myeloproliferative neoplasms (MPNs) are clonal disorders of hematopoietic stem cells that include BCR::ABL1-negative MPNs such as essential thrombocythemia (ET) and primary myelofibrosis (PMF). MPNs are rare in children, and knowledge of the genetics and biology of pediatric MPNs is very limited. Here, we report genetic variants in pediatric MPNs revealed by next generation sequencing (NGS).
Methods:
The study included nine pediatric patients (eight with ET and one with PMF) consecutively diagnosed between January 2000 and June 2023. NGS was performed on an Ion S5 XL Sequencer with the OncomineTM myeloid research assay using bone marrow aspirate samples.
Results:
Five patients (56%) had clinically significant genetic variants. Two patients with ET had JAK2 V617F (driver) and two patients with ET had FLT3 E656A and ETV6 I10V, respectively. A single patient with PMF had 10 variants in eight genes, including two previously reported nonsense variants (ASXL1 W960* and TET2 R1452*) and three novel variants (BCOR A997E, TET2 I2002Mfs*12, and ZRSR2 F86_E102del). Of all, one patient (11%) experienced an event of transient ischemic attack with visual loss for 5 minutes and one patient with PMF expired of septic shock four months after diagnosis.
Conclusions:
The results suggest a different genetic profile in pediatric MPN, with a lower incidence of driver variants in pediatric ET and multiple non-driver variants with poor prognostic implications in pediatric PMF.
Insights
Pediatric myeloproliferative neoplasms (MPNs) show unique genetic profiles. Next-generation sequencing revealed fewer driver mutations in essential thrombocythemia (ET) and multiple non-driver mutations in primary myelofibrosis (PMF) in children.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Myeloproliferative neoplasms (MPNs) are rare clonal disorders of hematopoietic stem cells.
- Pediatric MPNs, including essential thrombocythemia (ET) and primary myelofibrosis (PMF), have limited genetic and biological understanding.
- Next-generation sequencing (NGS) offers a powerful tool to investigate the genetic landscape of pediatric MPNs.
Purpose of the Study:
- To identify and characterize genetic variants in pediatric MPNs using NGS.
- To explore the genetic differences between pediatric and adult MPNs.
- To assess the clinical significance of identified genetic variants in pediatric MPN patients.
Main Methods:
- Nine pediatric patients (8 ET, 1 PMF) diagnosed between 2000-2023 were included.
- Bone marrow aspirate samples were analyzed using next-generation sequencing (NGS) on an Ion S5 XL Sequencer.
- The OncomineTM myeloid research assay was employed for comprehensive genetic variant detection.
Main Results:
- Clinically significant genetic variants were identified in 56% of pediatric MPN patients.
- Two ET patients harbored the JAK2 V617F driver mutation; two others had FLT3 and ETV6 variants.
- The single PMF patient exhibited 10 variants across eight genes, including novel mutations in BCOR, TET2, and ZRSR2.
Conclusions:
- Pediatric MPNs present a distinct genetic profile compared to adult forms.
- Pediatric ET shows a lower incidence of common driver mutations.
- Pediatric PMF is characterized by multiple non-driver variants, potentially indicating a poorer prognosis.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....